WMT News

J.P. Morgan analyst Christopher Horvers maintains a Neutral rating on Walmart. The retailer reported Q1 2025 adjusted EPS of $0.60, surpassing the $0.52 consensus, and sales of $161.51 billion, up 6.0% YoY. With a 15% EPS beat driven by strong margins and good U.S. comps, Walmart posted solid results, although comps slightly missed buyside expectations.

Walmart shares surge as Q1 2025 results surpass expectations with a 6% revenue increase to $161.51 billion and adjusted EPS of $0.60.

Someone with a lot of money to spend has taken a bearish stance on Walmart (NYSE:WMT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Walmart (NYSE:WMT) has observed the following analyst ratings within the last quarter:

Due To Lack Of Funds Quebec Medical Marijuana Service Won't Take New Patients Santé Cannabis, a no-fee medical cannabis service covered by Quebec's public health insurance announced it will not take on any new patients due to a lack of funding.

Walmart (NYSE:WMT) has outperformed the market over the past 5 years by 3.34% on an annualized basis producing an average annual return of 15.38%. Currently, Walmart has a market capitalization of $425.00 billion.